Sort   by:  
 Page size 
UnknownLongitudinal changes in white matter hyperintensity volume accelerate across the Alzheimer's continuum in adults with Down syndrome.
Not available
S-EPMC12434704 | biostudies-literature
UnknownMinimal Residual Disease in Myeloma: Application for Clinical Care and New Drug Registration.
Not available
S-EPMC9662886 | biostudies-literature
UnknownResistance and resilience to Alzheimer's disease in Down syndrome.
Not available
S-EPMC12035553 | biostudies-literature
UnknownDeconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging.
Not available
S-EPMC10995809 | biostudies-literature
Unknownγ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
Not available
S-EPMC11822357 | biostudies-literature
UnknownAssociation of Resilience-Related Life Experiences on Variability on Age of Onset in Dominantly Inherited Alzheimer Disease.
Not available
S-EPMC11399067 | biostudies-literature
UnknownComparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease.
Not available
S-EPMC11574007 | biostudies-literature
UnknownIntegrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer's disease.
Not available
S-EPMC11699654 | biostudies-literature
UnknownSoluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
Not available
S-EPMC8926925 | biostudies-literature
UnknownDownstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial.
Not available
S-EPMC11059071 | biostudies-literature
Sort   by:  
 Page size